REIN THERAPEUTICS INC (RNTX:NASDAQ)
$0.7748 0.0221 (2.9361%)
Analysed REIN THERAPEUTICS INC (RNTX:NASDAQ) News Sources
Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis
03-03-2026
yahoo.com
All You Need to Know About Rein Therapeutics Inc. (RNTX) Rating Upgrade to Buy
17-06-2026
yahoo.com
Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis
29-04-2026
yahoo.com
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
01-05-2026
yahoo.com
Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option
18-05-2026
yahoo.com
Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
11-06-2026
yahoo.com
Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
21-07-2026
yahoo.com
Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications
04-08-2026
yahoo.com
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
14-08-2026
yahoo.com
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
20-08-2026
yahoo.com
What is the current price of REIN THERAPEUTICS INC (RNTX:NASDAQ)?
The current price of REIN THERAPEUTICS INC (RNTX:NASDAQ) is $0.7748.
REIN THERAPEUTICS INC (RNTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of REIN THERAPEUTICS INC (RNTX:NASDAQ) since the previous trading day is $0.0221.
REIN THERAPEUTICS INC (RNTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of REIN THERAPEUTICS INC (RNTX:NASDAQ) since the previous trading day is 2.9361%.
What is the most recent average sentiment score for REIN THERAPEUTICS INC (RNTX:NASDAQ)?
The most recent average sentiment score for REIN THERAPEUTICS INC (RNTX:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for REIN THERAPEUTICS INC (RNTX:NASDAQ)?
The most recent sentiment for REIN THERAPEUTICS INC (RNTX:NASDAQ) is .
SEC-8K** Filing Available For REIN THERAPEUTICS INC (RNTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.